Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8525464 | Biomedicine & Pharmacotherapy | 2018 | 7 Pages |
Abstract
Our findings reveal that sanguinarine exhibits antitumor effects in epithelial ovarian cancer cells possible via regulating CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Sanguinarine may serve as a potential therapeutic reagent for epithelial ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Suxian Zhang, Tianyan Leng, Qin Zhang, Qinghua Zhao, Xiaofeng Nie, Lihua Yang,